Japan · Biopharma startup
Japan · Prism BioLab
Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.
Funding reportedLast round: Series C
What company datasets say Prism BioLab raised
Funding, as reported
Reported in all10.2Min the source's currency
Last roundSeries C
Investors listed5
On 3 portfolio pages
Investors who name them
Each firm lists Prism BioLab on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Prism BioLab in front of investors. Or tell us what we have wrong.